This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Dynavax Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.644. Dynavax Technologies's 10-Year median PS Ratio is 24.3491. Therefore, the Median PS Value for today is $40.03.
As of today (2024-04-19), Dynavax Technologies's share price is $11.80. Dynavax Technologies's Median PS Value is $40.03. Therefore, Dynavax Technologies's Price to Median PS Value for today is 0.29.
The historical rank and industry rank for Dynavax Technologies's Median PS Value or its related term are showing as below:
DVAX'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.06 Med: 0.43 Max: 85
Current: 0.29
During the past 13 years, the highest Price to Median PS Value of Dynavax Technologies was 85.00. The lowest was 0.06. And the median was 0.43.
DVAX's Price-to-Median-PS-Value is ranked better than 93.21% of 501
companies
in the Drug Manufacturers industry
Industry Median: 0.77
vs DVAX: 0.29
Dynavax Technologies Median PS Value Historical Data
The historical data trend for Dynavax Technologies's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Dynavax Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynavax Technologies Price-to-Median-PS-Value Distribution
For the Drug Manufacturers industry and Healthcare sector, Dynavax Technologies's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Dynavax Technologies's Price-to-Median-PS-Value falls into.
Dynavax Technologies Median PS Value Calculation
Dynavax Technologies's Median PS Value for today is calculated as
10-Year Median PS Ratio is 24.3491.
Dynavax Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.644.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynavax Technologies (NAS:DVAX) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Dynavax Technologies's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
11.80
/
40.03
=
0.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynavax Technologies Median PS Value Related Terms
Thank you for viewing the detailed overview of Dynavax Technologies's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Dynavax Technologies (Dynavax Technologies) Business Description
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DVAX has been successfully added to your 